ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $604 | -35.1% | 5,077 | -2.7% | 0.00% | -50.0% |
| Q2 2023 | $930 | +6.0% | 5,217 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $877 | +3.8% | 5,316 | -0.9% | 0.00% | 0.0% |
| Q4 2022 | $845 | -100.0% | 5,366 | -81.2% | 0.00% | -83.3% |
| Q3 2022 | $4,303,000 | -8.2% | 28,570 | +0.2% | 0.01% | 0.0% |
| Q2 2022 | $4,689,000 | -26.0% | 28,523 | +0.2% | 0.01% | 0.0% |
| Q1 2022 | $6,338,000 | +61.8% | 28,468 | +72.6% | 0.01% | +50.0% |
| Q4 2021 | $3,916,000 | -0.5% | 16,497 | -2.1% | 0.01% | 0.0% |
| Q3 2021 | $3,934,000 | +71.3% | 16,858 | +51.1% | 0.01% | +60.0% |
| Q2 2021 | $2,296,000 | +99.1% | 11,160 | +98.9% | 0.01% | +66.7% |
| Q1 2021 | $1,153,000 | -3.3% | 5,611 | +1.0% | 0.00% | 0.0% |
| Q4 2020 | $1,192,000 | +14.6% | 5,557 | -2.3% | 0.00% | 0.0% |
| Q3 2020 | $1,040,000 | -2.7% | 5,690 | -1.9% | 0.00% | 0.0% |
| Q2 2020 | $1,069,000 | +5.4% | 5,800 | +15.4% | 0.00% | -25.0% |
| Q1 2020 | $1,014,000 | +7.9% | 5,024 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $940,000 | +18.1% | 5,024 | +0.7% | 0.00% | +50.0% |
| Q3 2019 | $796,000 | -28.5% | 4,990 | +12.9% | 0.00% | -33.3% |
| Q2 2019 | $1,113,000 | +8.1% | 4,419 | +2.7% | 0.00% | 0.0% |
| Q1 2019 | $1,030,000 | +6.7% | 4,302 | +2.3% | 0.00% | 0.0% |
| Q4 2018 | $965,000 | -13.9% | 4,204 | +6.0% | 0.00% | -25.0% |
| Q3 2018 | $1,121,000 | +9.9% | 3,965 | +14.2% | 0.00% | +33.3% |
| Q2 2018 | $1,020,000 | +17.0% | 3,472 | +0.5% | 0.00% | 0.0% |
| Q1 2018 | $872,000 | -56.7% | 3,454 | -62.9% | 0.00% | -57.1% |
| Q4 2017 | $2,012,000 | +18.6% | 9,314 | +2.0% | 0.01% | +16.7% |
| Q3 2017 | $1,697,000 | +8.4% | 9,130 | +0.7% | 0.01% | 0.0% |
| Q2 2017 | $1,565,000 | -29.0% | 9,070 | -37.2% | 0.01% | -40.0% |
| Q1 2017 | $2,205,000 | -66.9% | 14,440 | -68.1% | 0.01% | -66.7% |
| Q4 2016 | $6,666,000 | +13.2% | 45,240 | -2.9% | 0.03% | +11.1% |
| Q3 2016 | $5,889,000 | +646.4% | 46,600 | +565.7% | 0.03% | +575.0% |
| Q2 2016 | $789,000 | +13.9% | 7,000 | +5.1% | 0.00% | +33.3% |
| Q1 2016 | $693,000 | -0.6% | 6,660 | +7.8% | 0.00% | 0.0% |
| Q4 2015 | $697,000 | +7.9% | 6,180 | +4.7% | 0.00% | 0.0% |
| Q3 2015 | $646,000 | +25.0% | 5,900 | +9.3% | 0.00% | 0.0% |
| Q2 2015 | $517,000 | +10.9% | 5,400 | +8.0% | 0.00% | 0.0% |
| Q1 2015 | $466,000 | +16.2% | 5,000 | +2.0% | 0.00% | +50.0% |
| Q4 2014 | $401,000 | +27.7% | 4,900 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $314,000 | +5.4% | 4,900 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $298,000 | +2.8% | 4,900 | +1.0% | 0.00% | 0.0% |
| Q1 2014 | $290,000 | -5.2% | 4,850 | +1.0% | 0.00% | 0.0% |
| Q4 2013 | $306,000 | -4.1% | 4,800 | +2.1% | 0.00% | 0.0% |
| Q3 2013 | $319,000 | -5.9% | 4,700 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $339,000 | – | 4,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |